Adorni MP - Search Results

1

Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line.

Lupo MG, Biancorosso N, Brilli E, Tarantino G, Adorni MP, Vivian G, Salvalaio M, Dall'Acqua S, Sut S, Neutel C, Chen H, Bressan A, Faggin E, Rattazzi M, Ferri N. Lupo MG, et al. Among authors: adorni mp. Nutrients. 2020 Feb 9;12(2):436. doi: 10.3390/nu12020436. Nutrients. 2020. PMID: 32050453 Free PMC article.

2

Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.

Zimetti F, Caffarra P, Ronda N, Favari E, Adorni MP, Zanotti I, Bernini F, Barocco F, Spallazzi M, Galimberti D, Ricci C, Ruscica M, Corsini A, Ferri N. Zimetti F, et al. Among authors: adorni mp. J Alzheimers Dis. 2017;55(1):315-320. doi: 10.3233/JAD-160411. J Alzheimers Dis. 2017. PMID: 27662294 Free article.

3

Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.

Adorni MP, Cipollari E, Favari E, Zanotti I, Zimetti F, Corsini A, Ricci C, Bernini F, Ferri N. Adorni MP, et al. Atherosclerosis. 2017 Jan;256:1-6. doi: 10.1016/j.atherosclerosis.2016.11.019. Epub 2016 Nov 16. Atherosclerosis. 2017. PMID: 27940374

4

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9.

Adorni MP, Ferri N, Marchianò S, Trimarco V, Rozza F, Izzo R, Bernini F, Zimetti F. Adorni MP, et al. Ther Clin Risk Manag. 2017 Dec 11;13:1555-1562. doi: 10.2147/TCRM.S144121. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 29270015 Free PMC article.

5

PCSK9 induces a pro-inflammatory response in macrophages.

Ricci C, Ruscica M, Camera M, Rossetti L, Macchi C, Colciago A, Zanotti I, Lupo MG, Adorni MP, Cicero AFG, Fogacci F, Corsini A, Ferri N. Ricci C, et al. Among authors: adorni mp. Sci Rep. 2018 Feb 2;8(1):2267. doi: 10.1038/s41598-018-20425-x. Sci Rep. 2018. PMID: 29396513 Free PMC article.

6

Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease.

Adorni MP, Ruscica M, Ferri N, Bernini F, Zimetti F. Adorni MP, et al. Front Aging Neurosci. 2019 May 22;11:120. doi: 10.3389/fnagi.2019.00120. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31178716 Free PMC article.

7

Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.

Ruscica M, Zimetti F, Adorni MP, Sirtori CR, Lupo MG, Ferri N. Ruscica M, et al. Among authors: adorni mp. Pharmacol Res. 2020 Mar;153:104653. doi: 10.1016/j.phrs.2020.104653. Epub 2020 Jan 10. Pharmacol Res. 2020. PMID: 31931117 Review.

8

Naturally Occurring PCSK9 Inhibitors.

Adorni MP, Zimetti F, Lupo MG, Ruscica M, Ferri N. Adorni MP, et al. Nutrients. 2020 May 16;12(5):1440. doi: 10.3390/nu12051440. Nutrients. 2020. PMID: 32429343 Free PMC article. Review.

9

PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin.

Lupo MG, Marchianò S, Adorni MP, Zimetti F, Ruscica M, Greco MF, Corsini A, Ferri N. Lupo MG, et al. Among authors: adorni mp. Int J Mol Sci. 2021 Apr 16;22(8):4114. doi: 10.3390/ijms22084114. Int J Mol Sci. 2021. PMID: 33923431 Free PMC article.

10

Nutrition Intervention and Cardiovascular Disease.

Adorni MP, Ferri N. Adorni MP, et al. Nutrients. 2022 Mar 30;14(7):1435. doi: 10.3390/nu14071435. Nutrients. 2022. PMID: 35406048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page